Date posted: November 4, 2014, 6:00 am
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
Date posted: October 21, 2014, 6:00 am
In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels.
Date posted: October 7, 2014, 6:00 am
In this episode, we have a roundtable discussion regarding ASHP Midyear and the process of pursuing a pharmacy residency program.
Date posted: September 23, 2014, 6:00 am
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
Date posted: September 9, 2014, 6:00 am
In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo).
Date posted: August 26, 2014, 6:00 am
In this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald.
Date posted: August 12, 2014, 6:00 am
In this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications.
Date posted: July 29, 2014, 6:00 am
In this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs.
Date posted: July 15, 2014, 6:00 am
In this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP).
Date posted: July 1, 2014, 6:00 am
In this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines.